Formulation Development
FORMULATION DEVELOPMENT WHITE PAPERS & ARTICLES
-
Nasal Delivery: Strategies For Success
A strengthened partnership enhances manufacturing for an ultra‑rare disease therapy, leveraging advanced containment upgrades to improve safety, reliability, capacity, and maintain global patient access.
-
How To Choose The Appropriate Filter Material For Every Sample
Membrane compatibility plays a crucial role in reliable sample filtration. Knowing how different filter materials interact helps prevent common workflow issues and supports efficient filtration.
-
A CDMO Is The Nexus Between Green Chemistry And Commercialization
Modern R&D transforms sustainability from an optional add-on into a strategic optimization tool, enhancing cost-efficiency, speed to market, and process intensification for drug developers.
-
Why Reshoring Is An Essential Strategy For ADC Supply Chain Security
Biotechs reshoring their supply chains to Western regions to mitigate risk and improve reliability require experienced partners to effectively manage these complex transitions.
-
A Patented Process For Intermediates Useful For Upadacitinib
Discover how innovative and safer synthetic strategies can streamline the manufacture of Upadacitinib while addressing the complexity and safety challenges inherent in its key intermediates.
FORMULATION DEVELOPMENT APPLICATIONS & STUDIES
-
Ultra-Low Cross-Linked Microgel Purification
ULC microgel purification is often slowed by linear polymer contamination and limitations of centrifugation. Explore how hollow fiber TFF improves filtration efficiency and supports scalable processing.
-
mRNA Manufacturing With Fed-Batch In Vitro Transcription
A milliliter-scale approach to IVT optimization reveals how controlled feeding, precise pH management, and real-time monitoring can boost mRNA yield and streamline scale-up to larger bioreactor volumes.
-
Development Of A Non-Standard Protein Therapeutic
Discover how a tailored development approach transformed a complex therapeutic protein into a candidate ready for early-stage clinical trials.
-
MicroCoat™ Technology DFor Taste-Masking Amodiaquine, Artesunate In Oral Antimalarial Formulations
Drive forward the development and adoption of taste‑masked ASAQ micropellets so children in low‑resource settings can receive life‑saving antimalarial treatment that is both effective and easy to take.
-
Using DSC And MDSC To Study Material Interactions Of APIs And Excipients
Thermal analysis reveals how particle size and morphology influence material interactions and stability. Learn how DSC and MDSC techniques uncover compatibility issues and guide better excipient selection.
FORMULATION DEVELOPMENT SOLUTIONS
- Trusted End-To-End CDMO Partner For Your Journey
- Is NSA Sabotaging Your Lab's Productivity
- Largest Global Network Of Harmonized GMP Product Testing Laboratories
- Accelerating FIH Trials To POC With Speed, Safety, And Certainty
- Dynamic And Ergonomic Oligosynthesis Column
- Resin Offering High Productivity And Robust Processes
- Developing Palatable, Age Appropriate Drug Products
- Oligonucleotide Discovery And Development
- Be Unstoppable With Comprehensive Charge Variant Analysis
- CDO Services: Agile. Flexible. Focused On You.
PHARMACEUTICAL AND FORMULATION DEVELOPMENT NEWS
- Strategic Oral Solid Dose Facility Investment In Ireland Expands Novo Nordisk's Global Manufacturing Footprint
- Novartis Announces New Radioligand Therapy Manufacturing Facility In Denton, Texas
- Quotient Sciences Extends Commercial Manufacturing Partnership For Ultra-Rare Disease Treatment
- Bora Pharmaceuticals And GSK Sign $250M Five Year Global Manufacturing Contract
- AbbVie Announces $380 Million Investment With Two New Active Pharmaceutical Ingredient Manufacturing Facilities In Illinois
- Johnson & Johnson Announces $1 Billion Investment With New Cell Therapy Manufacturing Facility In Pennsylvania
- Esco Philippines Returns To The 41st PSNM Annual Convention: Supporting Innovation In Nuclear Medicine
- Syntegon Launches AIM9 High-Speed Inspection Platform
- JHS CEO Chris Preti Receives 2026 Person Of Influence Award
- Subcutaneously Administered Nanotrastuzumab Matches Performance Of Herceptin HYLECTA In Minipig Study